×

malignant mesothelioma meaning in Chinese

恶性间皮瘤

Examples

  1. Malignant mesothelioma of peritoneum : a case report
    腹膜恶性间皮瘤1例
  2. Malignant mesothelioma is a disease in which cancer ( malignant ) cells are found in the sac lining the chest ( the pleura ) or abdomen ( the peritoneum )
    恶性间皮瘤是一种疾病,其中癌症(癌)细胞中发现,在校舍衬砌胸部(胸膜)或腹部(腹膜)
  3. The chance of recovery ( prognosis ) depends on the size of the cancer , where the cancer is , how far the cancer has spread , your age , how the cancer cells look under the microscope , how the asbestos cancer or malignant mesothelioma responds to treatment
    他们的痊愈机会(预后)取决于大小的癌症,癌症是,多远癌细胞已蔓延,你的年龄,怎麽癌细胞看在显微镜下,如何石棉癌或恶性间皮瘤回应的待遇
  4. Objective to study clinicopathologic features and to analyze differential of malignant mesothelioma . methods a case of malignant mesothelioma of the mediastinum was observed with pathologic examination and the literaturenas briefly reviewed . results the malignant mesothelioma showed biphasic forms , fibrous component and neoplastic cells arranged in stream - or nest - or cabinet - like forms , immumohistochemical staining showed that the neoplastic cells were positive for vimentin , desmin , nse , cd99 , cea , myod1 . conclusion malignant mesothelioma of mediastinum is a relatively rare poor prognosis , with the combination of clinical histopathological and immunohistochemical data , its correct diagnosis and differential diagnosis can be made
    恶性间皮瘤发病率很低,大部分发生于胸膜和心包膜1 ,此瘤临床无特异性症状和体征,需与其他纵隔肿瘤相鉴别,方能作出正确诊断,现将1例纵隔恶性间皮瘤的临床病理资料报告如下,并结合文献对该肿瘤的形态结构特点、诊断与鉴别诊断、治疗与预后进行讨论。

Related Words

  1. diffuse malignant mesothelioma of pleura
  2. malignant glaucoma
  3. malignant mesenchymoma
  4. malignant erythrocytosis
  5. malignant change
  6. malignant chorioepithelioma
  7. malignant reticulohistiocytosis
  8. malignant dysentery
  9. malignant blister
  10. malignant hyperplasia
  11. malignant mesenchymoma of liver
  12. malignant mesothe
  13. malignant mesothelioma of pleura
  14. malignant midline reticulosis
PC Version

Copyright © 2018 WordTech Co.